Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.


Scandinavian Biopharma is once again looking back on a highly successful business year

2018-05-22

2017 was another successful year with continued strong growth for the Swedish biotech company Scandinavian Biopharma. “We can look back on an amazing year. We are very proud to report completion of a large Phase I/II child study in Bangladesh, we were awarded 30 MSEK from Horizon 2020 SME and we kick-started a Phase IIB […]

Our Phase IIB study on the BBC news!

2018-05-09

The BBC reporter Mandeep Rai has been to the village Grand Popo in Benin where the trial is taking place, to meet some of the volunteers and the lead scientist Anu Kantele. https://www.bbc.co.uk/programmes/p066509w    

Meet Scandinavian Biopharma at Northern European Conference on Travel Medicine (NECTM 7) in Stockholm

2018-04-27

From May 2nd to May 4th, over 500 delegates will gather in Stockholm for the main Travel medicine conference in 2018. The conference fosters travel medicine in Europe. NECTM is an association formed by medical medicine associations in the Nordic countries, the United Kingdom, Germany, Ireland and the Netherlands. The conference has a comprehensive scientific program […]